MENU
TNYA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tenaya Therapeutics (TNYA) Ownership - Who owns Tenaya Therapeutics?
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease... Show more
Profile
Industry
N/A
Address
171 Oyster Point Boulevard
Phone
+1 650 825-6990
Employees
140
Web
https://www.tenayatherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
73.16M
P/E Ratio
N/A
Total Cash
61.45M
Projected Growth
N/A
Total Debt
13.61M
Revenue
N/A
Risk (Beta)
2.96
Dividend Yield
N/A
Total Cash/Share
0.38
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TNYA
Capitalization
73.2M
P/E Ratio
N/A
Risk (Beta)
2.96
Dividend Yield
N/A
Total Cash
61.4M
Total Cash/Share
0.38
Total Debt
13.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
92.9M
P/B Ratio
0.79
Cash Flow
N/A
Earnings
-1.31
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8K
Current Ratio
4.22
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-107.48M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-76.52
Shares Held By Institutions
114M
Shares Outstanding - Current
163M
Total Liabilities
27.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-68.531
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
171 Oyster Point Boulevard
Phone
+1 650 825-6990
Employees
140
Web
https://www.tenayatherapeutics.com